Evidence map›Paper›PMID 24587191›Full record

ArticlePloS one2014

Elevated exhaled nitric oxide in allergen-provoked asthma is associated with airway epithelial iNOS.

Abraham B Roos, Michiko Mori, Reidar Grönneberg, Christina Österlund, Hans-Erik Claesson, Jan Wahlström, Johan Grunewald, Anders Eklund, Jonas S Erjefält, Jon O Lundberg and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. A molecular systems architecture of asthma.Frontiers in immunology · 2026
    Pooled it
  2. Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2016
    Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Preparation and Safety Evaluation ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  9. Article
  10. Observational
  11. Review
  12. Review
  13. Article
  14. Relationship between Particulate Matter (PMCanadian respiratory journal · 2020
    Article
  15. Bioenergetic Differences in the Airway Epithelium of LeanAntioxidants & redox signaling · 2019
    Article
  16. Severe Eosinophilic Asthma.Journal of clinical medicine · 2019
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Abraham B RoosDepartment of Medicine, Solna, Respiratory Medicine Unit, Karolinska Institutet, Stockholm, Sweden ; Department of Experimental Medical Science, Lund University, Lund, Sweden.
Michiko MoriDepartment of Experimental Medical Science, Lund University, Lund, Sweden.
Reidar GrönnebergDepartment of Medicine, Solna, Respiratory Medicine Unit, Karolinska Institutet, Stockholm, Sweden.
Christina ÖsterlundDepartment of Medicine, Division of Hematology, Karolinska Institutet, Stockholm, Sweden.
Hans-Erik ClaessonDepartment of Medicine, Division of Hematology, Karolinska Institutet, Stockholm, Sweden.
Jan WahlströmDepartment of Medicine, Solna, Respiratory Medicine Unit, Karolinska Institutet, Stockholm, Sweden.
Johan GrunewaldDepartment of Medicine, Solna, Respiratory Medicine Unit, Karolinska Institutet, Stockholm, Sweden.
Anders EklundDepartment of Medicine, Solna, Respiratory Medicine Unit, Karolinska Institutet, Stockholm, Sweden.
Jonas S ErjefältDepartment of Experimental Medical Science, Lund University, Lund, Sweden.
Jon O LundbergDepartment of Physiology and Pharmacology, Section of Pharmacological Nitric Oxide Research, Karolinska Institutet, Stockholm, Sweden.
Magnus NordDepartment of Medicine, Solna, Respiratory Medicine Unit, Karolinska Institutet, Stockholm, Sweden ; Safety Science, Global Regulatory Affairs & Patient Safety, AstraZeneca Global Medicines Development, Mölndal, Sweden.
Karolinska Institutet · SELund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFractional exhaled nitric oxide is elevated in allergen-provoked asthma. The cellular and molecular source of the elevated fractional exhaled nitric oxide is, however, uncertain.

objectiveTo investigate whether fractional exhaled nitric oxide is associated with increased airway epithelial inducible nitric oxide synthase (iNOS) in allergen-provoked asthma.

methodsFractional exhaled nitric oxide was measured in healthy controls (n = 14) and allergic asthmatics (n = 12), before and after bronchial provocation to birch pollen out of season. Bronchoscopy was performed before and 24 hours after allergen provocation. Bronchial biopsies and brush biopsies were processed for nitric oxide synthase activity staining with nicotinamide adenine dinucleotide phosphate diaphorase (NADPH-d), iNOS immunostaining, or gene expression analysis of iNOS by real-time PCR. NADPH-d and iNOS staining were quantified using automated morphometric analysis.

resultsFractional exhaled nitric oxide and expression of iNOS mRNA were significantly higher in un-provoked asthmatics, compared to healthy controls. Allergic asthmatics exhibited a significant elevation of fractional exhaled nitric oxide after allergen provocation, as well as an accumulation of airway eosinophils. Moreover, nitric oxide synthase activity and expression of iNOS was significantly increased in the bronchial epithelium of asthmatics following allergen provocation. Fractional exhaled nitric oxide correlated with eosinophils and iNOS expression.

conclusionHigher fractional exhaled nitric oxide concentration among asthmatics is associated with elevated iNOS mRNA in the bronchial epithelium. Furthermore, our data demonstrates for the first time increased expression and activity of iNOS in the bronchial epithelium after allergen provocation, and thus provide a mechanistic explanation for elevated fractional exhaled nitric oxide in allergen-provoked asthma.

Indexed as

AllergensPollenAdultAsthmaBronchiBronchial Provocation TestsCase-Control StudiesEpithelial CellsExhalationFemaleGene ExpressionHumansMaleMiddle AgedNADPH DehydrogenaseNitric OxideAllergensNADPH DehydrogenaseNitric OxideNitric Oxide Synthase Type IINOS2 protein, humanRNA, Messenger

Identifiers

PMID24587191
PMCPMC3938593
OpenAlexW1992270428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.